ID
20056
Description
NCT01117584 Astellas Phase 2b, Double-Blind, Randomized, Multicenter, Parallel Group, Placebo-Controlled, Dose-Finding Study to Evaluate the Efficacy, Safety and Tolerability of a 12- Week Treatment with ASP1941 in Combination with Metformin in Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Alone.
Keywords
Versions (2)
- 12/30/16 12/30/16 -
- 2/4/17 2/4/17 -
Uploaded on
February 4, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
End of Study: Breaking the Blind [BB_1] NCT01117584
End of Study: Breaking the Blind [BB_1] NCT01117584
- StudyEvent: ODM
Similar models
End of Study: Breaking the Blind [BB_1] NCT01117584
- StudyEvent: ODM
C0175566 (UMLS CUI [1,2])
C0175566 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0175566 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,3])
C0175566 (UMLS CUI [1,2])
C1272683 (UMLS CUI [1,3])
C0027361 (UMLS CUI [1,4])
C0175566 (UMLS CUI [1,2])
C0027361 (UMLS CUI [1,3])
C0008972 (UMLS CUI [1,2])
C0175566 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
No comments